In accordance with regulation 74(5) of the DP Regulations and based on the certificate received from MUFG Intime India (formerly known as Link Intime India (‘RTA’), Zydus Lifesciences has confirmed that for the quarter ended on September 30, 2025, the certificates of equity shares received for dematerialization have been mutilated and cancelled only after due verification and that the name of the respective depository has been substituted as the registered owner in respect of those dematerialized equity shares. Further it has confirmed that the securities comprised in the said certificates of equity shares have been listed on BSE and the National Stock Exchange of India where the earlier issued securities are listed.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1652.00 |
| Dr. Reddys Lab | 1235.20 |
| Cipla | 1211.30 |
| Zydus Lifesciences | 923.10 |
| Lupin | 2312.35 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: